Toll Free: 1-888-928-9744

Cocrystal Pharma, Inc. - Product Pipeline Review - 2016

Published: Jun, 2016 | Pages: 44 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Cocrystal Pharma, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Cocrystal Pharma, Inc. - Product Pipeline Review - 2016', provides an overview of the Cocrystal Pharma, Inc.'s pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Cocrystal Pharma, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Cocrystal Pharma, Inc.
- The report provides overview of Cocrystal Pharma, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Cocrystal Pharma, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Cocrystal Pharma, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Cocrystal Pharma, Inc.'s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Cocrystal Pharma, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Cocrystal Pharma, Inc.'s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
 Table of Contents
Table of Contents 2 List of Tables 5 List of Figures 5 Cocrystal Pharma, Inc. Snapshot 6 Cocrystal Pharma, Inc. Overview 6 Key Information 6 Key Facts 6 Cocrystal Pharma, Inc. - Research and Development Overview 7 Key Therapeutic Areas 7 Cocrystal Pharma, Inc. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Out-Licensed Products 12 Out-Licensed Products/Combination Treatment Modalities 13 Cocrystal Pharma, Inc. - Pipeline Products Glance 14 Cocrystal Pharma, Inc. - Clinical Stage Pipeline Products 14 Phase I Products/Combination Treatment Modalities 14 Cocrystal Pharma, Inc. - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Cocrystal Pharma, Inc. - Drug Profiles 17 CC-31244 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 CC-1845 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 CC-2068 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 CC-2069 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 CDI-244 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Gene Therapy for Hepatitis B and Human Papilloma Virus Infections 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 CC-31326 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 RS-1137 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 RS-1142 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 RS-1145 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 RS-930 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 RS-961 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Small Molecule for Hepatitis C 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Small Molecules to Inhibit PB2 for Influenza 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Small Molecules to Inhibit RNA Dependent RNA Polymerase for Common Cold 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Small Molecules to Inhibit RNA Dependent RNA Polymerase for Dengue Virus Infections 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Small Molecules to Inhibit RNA Dependent RNA Polymerase for Norovirus Infections 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Cocrystal Pharma, Inc. - Pipeline Analysis 34 Cocrystal Pharma, Inc. - Pipeline Products by Target 34 Cocrystal Pharma, Inc. - Pipeline Products by Route of Administration 35 Cocrystal Pharma, Inc. - Pipeline Products by Molecule Type 36 Cocrystal Pharma, Inc. - Pipeline Products by Mechanism of Action 37 Cocrystal Pharma, Inc. - Recent Pipeline Updates 38 Cocrystal Pharma, Inc. - Dormant Projects 41 Cocrystal Pharma, Inc. - Locations And Subsidiaries 42 Head Office 42 Other Locations & Subsidiaries 42 Appendix 43 Methodology 43 Coverage 43 Secondary Research 43 Primary Research 43 Expert Panel Validation 43 Contact Us 43 Disclaimer 44
List of Tables
Cocrystal Pharma, Inc., Key Information 6 Cocrystal Pharma, Inc., Key Facts 6 Cocrystal Pharma, Inc. - Pipeline by Indication, 2016 8 Cocrystal Pharma, Inc. - Pipeline by Stage of Development, 2016 10 Cocrystal Pharma, Inc. - Monotherapy Products in Pipeline, 2016 11 Cocrystal Pharma, Inc. - Out-Licensed Products in Pipeline, 2016 12 Cocrystal Pharma, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016 13 Cocrystal Pharma, Inc. - Phase I, 2016 14 Cocrystal Pharma, Inc. - Preclinical, 2016 15 Cocrystal Pharma, Inc. - Discovery, 2016 16 Cocrystal Pharma, Inc. - Pipeline by Target, 2016 34 Cocrystal Pharma, Inc. - Pipeline by Route of Administration, 2016 35 Cocrystal Pharma, Inc. - Pipeline by Molecule Type, 2016 36 Cocrystal Pharma, Inc. - Pipeline Products by Mechanism of Action, 2016 37 Cocrystal Pharma, Inc. - Recent Pipeline Updates, 2016 38 Cocrystal Pharma, Inc. - Dormant Developmental Projects,2016 41 Cocrystal Pharma, Inc., Other Locations 42



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify